256 related articles for article (PubMed ID: 7518837)
1. Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation.
Sugita K; Nojima Y; Tachibana K; Soiffer RJ; Murray C; Schlossman SF; Ritz J; Morimoto C
J Clin Invest; 1994 Aug; 94(2):481-8. PubMed ID: 7518837
[TBL] [Abstract][Full Text] [Related]
2. Altered tyrosine phosphorylation via the very late antigen (VLA)/beta1 integrin stimulation is associated with impaired T-cell signaling through VLA-4 after allogeneic bone marrow transplantation.
Sato T; Ohashi Y; Tachibana K; Soiffer RJ; Ritz J; Morimoto C
Blood; 1997 Nov; 90(10):4222-9. PubMed ID: 9354695
[TBL] [Abstract][Full Text] [Related]
3. Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation.
Kameoka J; Sato T; Torimoto Y; Sugita K; Soiffer RJ; Schlossman SF; Ritz J; Morimoto C
Blood; 1995 Feb; 85(4):1132-7. PubMed ID: 7849301
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules.
Davis LS; Oppenheimer-Marks N; Bednarczyk JL; McIntyre BW; Lipsky PE
J Immunol; 1990 Aug; 145(3):785-93. PubMed ID: 1695644
[TBL] [Abstract][Full Text] [Related]
5. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin.
Shimizu Y; van Seventer GA; Horgan KJ; Shaw S
J Immunol; 1990 Jul; 145(1):59-67. PubMed ID: 1972721
[TBL] [Abstract][Full Text] [Related]
6. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.
Sugita K; Soiffer RJ; Murray C; Schlossman SF; Ritz J; Morimoto C
Transplantation; 1994 May; 57(10):1465-73. PubMed ID: 7910987
[TBL] [Abstract][Full Text] [Related]
7. Comitogenic effects of very late activation antigens on CD3-stimulated human thymocytes. Involvement of various tyrosine kinase pathways.
Ticchioni M; Deckert M; Bernard G; Calandra D; Breittmeyer JP; Imbert V; Peyron JF; Bernard A
J Immunol; 1995 Feb; 154(3):1207-15. PubMed ID: 7529794
[TBL] [Abstract][Full Text] [Related]
8. Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein.
Nojima Y; Rothstein DM; Sugita K; Schlossman SF; Morimoto C
J Exp Med; 1992 Apr; 175(4):1045-53. PubMed ID: 1372641
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system.
Yamada A; Nojima Y; Sugita K; Dang NH; Schlossman SF; Morimoto C
Eur J Immunol; 1991 Feb; 21(2):319-25. PubMed ID: 1705510
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
Blood; 1990 May; 75(10):2076-84. PubMed ID: 1970938
[TBL] [Abstract][Full Text] [Related]
11. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of protein tyrosine phosphorylation in human B cells after ligation of the beta 1 integrin VLA-4.
Freedman AS; Rhynhart K; Nojima Y; Svahn J; Eliseo L; Benjamin CD; Morimoto C; Vivier E
J Immunol; 1993 Mar; 150(5):1645-52. PubMed ID: 7679689
[TBL] [Abstract][Full Text] [Related]
13. Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
Nagler A; Rabinowitz R; Rosengolts-Rat J; Condiotti R; Schlesinger M
J Hematother Stem Cell Res; 2000 Feb; 9(1):63-75. PubMed ID: 10738973
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of Crk-associated substrate lymphocyte-type is a critical element in TCR- and beta 1 integrin-induced T lymphocyte migration.
Ohashi Y; Iwata S; Kamiguchi K; Morimoto C
J Immunol; 1999 Oct; 163(7):3727-34. PubMed ID: 10490968
[TBL] [Abstract][Full Text] [Related]
15. Regulation of T cell proliferation by anti-CD49d and anti-CD29 monoclonal antibodies.
Bednarczyk JL; Teague TK; Wygant JN; Davis LS; Lipsky PE; McIntyre BW
J Leukoc Biol; 1992 Oct; 52(4):456-62. PubMed ID: 1383369
[TBL] [Abstract][Full Text] [Related]
16. Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation.
Burkly LC; Jakubowski A; Newman BM; Rosa MD; Chi-Rosso G; Lobb RR
Eur J Immunol; 1991 Nov; 21(11):2871-5. PubMed ID: 1718763
[TBL] [Abstract][Full Text] [Related]
17. VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin.
Nojima Y; Humphries MJ; Mould AP; Komoriya A; Yamada KM; Schlossman SF; Morimoto C
J Exp Med; 1990 Oct; 172(4):1185-92. PubMed ID: 1976737
[TBL] [Abstract][Full Text] [Related]
18. Role of the VLA-4 molecule in T cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4.
Sato T; Tachibana K; Nojima Y; D'Avirro N; Morimoto C
J Immunol; 1995 Sep; 155(6):2938-47. PubMed ID: 7673711
[TBL] [Abstract][Full Text] [Related]
19. Role of LFA-1, CD2, VLA-5/CD29, and CD43 surface receptors in CD4+ T cell adhesion to B cells.
Lecomte O; Hauss P; Barbat C; Mazerolles F; Fischer A
Cell Immunol; 1994 Oct; 158(2):376-88. PubMed ID: 7522975
[TBL] [Abstract][Full Text] [Related]
20. Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor.
Yamada A; Nikaido T; Nojima Y; Schlossman SF; Morimoto C
J Immunol; 1991 Jan; 146(1):53-6. PubMed ID: 1670606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
